SCHEMBL20162125

SCHEMBL20162125

CN(C)C(On1ccccc1=O)=[N+](C)C.F[P-](F)(F)(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3181936 0.94
SCHEMBL386750 0.89
SCHEMBL5371444 0.77 POLB (0.43)
SCHEMBL29776742 0.75
SCHEMBL15946654 0.72 ALDH1A1 (0.31)
SCHEMBL29357885 0.68 ALDH1A1 (0.43)
SCHEMBL16858647 0.68 GAA (0.36)
SCHEMBL13479829 0.68 ALDH1A1 (0.34)
SCHEMBL7825413 0.68 HTR2C (0.34)
SCHEMBL6694126 0.67 TSHR (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117843761-A Method for preparing melanocortin analogue cyclic peptide drug based on hydrophobic label carrier 浙江工业大学 2024-04-09 CN claimed
CN-117843715-A Liquid phase synthesis method of melanoputan-II 浙江工业大学 2024-04-09 CN claimed
CN-115093460-A Method for synthesizing linaclotide intermediate and linaclotide in full liquid phase 浙江工业大学 2022-09-23 CN claimed
EP-4039257-B1 PHARMACEUTICAL COMPOSITION AND KIT CONTAINING A PENAM DERIVATIVE OR SALT THEREOF AND ONE OR MORE COMPOUNDS SELECTED FROM BETA-LACTAMASE INHIBITOR COMPOUND, ANTIBACTERIAL COMPOUND AND SALTS OF THESE FUJIFILM CORP (JP) 2026-05-27 EP disclosed
US-20260137765-A1 METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF INSTITUT CURIE (FR) 2026-05-21 US disclosed
US-12535942-B2 Blowout preventer system with data playback Hydril USA Distribution LLC (US) 2026-01-27 US disclosed
US-12527854-B2 Methods of producing Shiga toxin B-subunit (STxB) monomers and oligomers, and uses thereof INSTITUT CURIE (FR) 2026-01-20 US disclosed
WO-2025091137-A1 IMPLANTABLE DEVICE COMPOSITIONS INCLUDING ESTER BONDS VOLUMINA MEDICAL SA (CH) 2025-05-08 WO disclosed
US-12286440-B2 Penam derivative or salt thereof, pharmaceutical composition, and applications thereof FUJIFILM CORPORATION (JP) 2025-04-29 US disclosed
US-20250111889-A1 DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES UNIVERSITY OF WASHINGTON 2025-04-03 US disclosed
EP-3604305-B1 NOVEL PYRIDONE CARBOXYLIC ACID DERIVATIVE OR SALT THEREOF WAKUNAGA PHARMA CO LTD (JP) 2024-08-28 EP disclosed
EP-3327004-B1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND FUJIFILM CORP (JP) 2020-11-04 EP disclosed
EP-3693374-A1 NOVEL 2-CARBOXYPENAM COMPOUND OR SALT THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUND OR SALT, AND APPLICATION THEREOF Fujifilm Corporation (JP) 2020-08-12 EP disclosed
US-10696637-B2 Nitrogen-containing heterocyclic compound FUJIFILM CORPORATION (JP) 2020-06-30 US disclosed
US-10633343-B2 2020-04-28 US disclosed
EP-3563851-A1 ANTITUMOR AGENT AND BROMODOMAIN INHIBITOR FUJIFILM Corporation (JP) 2019-11-06 EP disclosed
US-20190314360-A1 ANTITUMOR AGENT AND BROMODOMAIN INHIBITOR FUJIFILM CORPORATION (JP) 2019-10-17 US disclosed
EP-3323811-B1 PRODUCTION METHOD FOR NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AND INTERMEDIATE OF SAID NITROGEN-CONTAINING HETEROCYCLIC COMPOUND FUJIFILM CORP (JP) 2019-05-08 EP disclosed
EP-3327004-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND Fujifilm Corporation (JP) 2018-05-30 EP disclosed
EP-3323811-A1 PRODUCTION METHOD FOR NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AND INTERMEDIATE OF SAID NITROGEN-CONTAINING HETEROCYCLIC COMPOUND FUJIFILM Corporation (JP) 2018-05-23 EP disclosed